Showing 191-200 of 472 results for "".
- Canadian Med Spa Owner Responds to Health Canada Warning Over Unauthorized Treatmentshttps://modernaesthetics.com/news/health-canada-issues-warning-over-unauthorized-treatments-at-med-spa/2473648/Christine Francoeur, the owner of MedSkin Laser Center in Alberta, Canada, addressed a recent Health Canada public advisory regarding her med spa. Health Canada issued a warning on August 2 stating unauthorized treatments were being administered by the owner and operator who were allegedly posing
- United Aesthetics Alliance appoints new chief executive officer, chief development officerhttps://modernaesthetics.com/news/united-aesthetics-alliance-appoints-new-chief-executive-officer-chief-development-officer/2473608/United Aesthetics Alliance (UAA) announced it has appointed Thomas Thill as chief executive officer and Benjamin Herbert as chief development officer to lead the company’s go-forward growth strategy. As an experienced healthcare leader, Thill joins UAA to build market-leadin
- 10xBio Completes Enrollment of Phase 2b Trial of Novel Drug for Submental Body Contouringhttps://modernaesthetics.com/news/10xbio-completes-enrollment-of-phase-2b-trial-of-novel-drug-for-submental-body-contouring/2473477/10xBio completed enrollment in a repeat treatment study of its novel injectable drug for submental body contouring. The drug, 10
- Evolus Unveils New Branding for Jeuveauhttps://modernaesthetics.com/news/evolus-unveils-new-branding-for-jeuveau/2473470/Evolus, Inc. is unveiling its new branding for Jeuveau (prabotulinumtoxinA-xvfs). The new Jeuveau imagery reflects today’s consumers, many of whom are millennials and younger. The “Jeuveau, You See Me” marketing campaign uses inclusive messaging to encourage
- Estée Lauder, Manchester United Partner to Boost Fans’ Skin Healthhttps://modernaesthetics.com/news/estee-lauder-manchester-united-partner-to-boost-fans-skin-health/2473451/Estée Lauder will team up with Manchester United, to reach and engage their extensive fanbase in China and the Asia Pacific region. Kicking off in Summer 2023, the partnership’s inaugural campaign will launch with players from Manchester United’s first team, inc
- Hairy Moles May Hold the Secret to Understanding Hair Growthhttps://modernaesthetics.com/news/hairy-moles-may-hold-the-secret-to-understanding-hair-growth/2473434/Do hairy moles hold the secret to understanding hair growth? Maybe, according to research published in the June 21, 2023 issue of Nature. Using a mouse model, researchers tracked the activit
- Body Contouring Doesn't Increase Long-term Weight Loss after Bariatric Surgery: Studyhttps://modernaesthetics.com/news/body-contouring-doesnt-increase-long-term-weight-loss-after-bariatric-surgery-study/2473421/For patients who experience massive weight loss after bariatric surgery, subsequent body contouring to remove excess skin is not itself associated with long-term weight loss, reports a
- FDA Clears Renuvion APR Handpiece for Coagulation of Subcutaneous Soft Tissues after Liposuction for Body Contouringhttps://modernaesthetics.com/news/fda-clears-renuvion-apr-handpiece-for-coagulation-of-subcutaneous-soft-tissues-after-liposuction-for-body-contouring/2473404/The U.S. Food and Drug Administration (FDA) cleared the Renuvion APR Handpiece for coagulation of subcutaneous soft tissues following liposuction for aesthetic body contouring. “The Renuvion APR handpiece is the only device to have a 510(k)
- EON Robotic Body Contouring Device Gains Additional FDA Clearance for Back and Thighshttps://modernaesthetics.com/news/eon-robotic-body-contouring-device-gains-additional-fda-clearance-for-back-and-thighs/2473380/EON Smarter Body Contouring has received FDA clearance for the back and thighs—the third FDA clearance for EON. The device was previously FDA-cleared for clinical providers to treat patients' full abdomen and flanks. Parent company Dominion Aesthetic Technologies describe
- U.S. FDA Clears Renuvion to Coagulate and Contract Soft Tissues, Including Subcutaneous Tissuehttps://modernaesthetics.com/news/fda-clears-of-renuvion-to-coagulate-and-contract-soft-tissues-including-subcutaneous-tissue/2473371/The U.S. Food and Drug Administration (FDA) has cleared the use of the Renuvion APR Handpiece for the delivery of radiofrequency energy and/or helium plasma where coagulation/contraction of soft tissue is needed. (Soft tissue includes subcutaneous tissue.) “We are pleas